phase 1_initiation
saveNational Institute of Neurological Disorders and Stroke — pembrolizumab (Phase I Trial Initiation)
community read0 votes
Therapy area: Infectious Disease. Indication: Coronavirus Disease 2019 (COVID-19), Post-Acute Sequelae of COVID 2019 (PASC or Long COVID)